Washida H, Tsugaya M, Hirao N, Sakagami H, Iwase Y
Jpn J Antibiot. 1985 Jun;38(6):1648-53.
Cefmenoxime (1 g) was intravenously administered by one shot to investigate its pharmacokinetic profile with respect to transfer into the kidney, vesical wall and prostatic adenoma. The concentration of cefmenoxime in the kidney reached a peak of 403 micrograms/g at 0.17 hour after administration. The biological half-life was 0.74 hour. In the vesical wall, the level of cefmenoxime reached a peak of 28 micrograms/g at 0.67 hour after administration. The half-life was 2.30 hours. The peak level of cefmenoxime in the prostatic adenoma was 22 micrograms/g at 0.39 hour after administration. The half-life was 2.90 hours. The concentrations of cefmenoxime in these urogenital tissues were higher than its MIC80 and MBC80 against various Gram-negative organisms.
静脉注射头孢甲肟(1克)一次,以研究其向肾脏、膀胱壁和前列腺腺瘤转移的药代动力学特征。给药后0.17小时,肾脏中头孢甲肟浓度达到峰值403微克/克。生物半衰期为0.74小时。在膀胱壁中,给药后0.67小时,头孢甲肟水平达到峰值28微克/克。半衰期为2.30小时。给药后0.39小时,前列腺腺瘤中头孢甲肟的峰值水平为22微克/克。半衰期为2.90小时。这些泌尿生殖组织中头孢甲肟的浓度高于其对各种革兰氏阴性菌的MIC80和MBC80。